tiprankstipranks
Advertisement
Advertisement

BRNS Stock Latest News

Barinthus Bio Announces 2025 Results and Clywedog Merger
Company AnnouncementsBarinthus Bio Announces 2025 Results and Clywedog Merger
12d ago
8K
BRNS
Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year
PremiumThe Fly
Barinthus Biotherapeutics reports FY25 EPS ($1.64) vs ($1.55) last year
12d ago
BRNS
Barinthus Biotherapeutics Amends Cross-Border Merger Agreement Terms
PremiumCompany Announcements
Barinthus Biotherapeutics Amends Cross-Border Merger Agreement Terms
30d ago
8K
BRNS
Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
PremiumCompany Announcements
Barinthus Biotherapeutics Receives Nasdaq Minimum Bid Price Notice
3M ago
8K
BRNS
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
PremiumRatings
Promising Clinical Trial Results and Strategic Merger Drive Buy Rating for Barinthus Biotherapeutics
3M ago
BRNS
Barinthus Biotherapeutics Updates on AVALON Trial Progress
PremiumCompany AnnouncementsBarinthus Biotherapeutics Updates on AVALON Trial Progress
3M ago
8K
BRNS
Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
Premium
The Fly
Barinthus Biotherapeutics announces update on Phase 1 trial of VTP-1000
3M ago
BRNS
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
Premium
Ratings
Buy Rating for Barinthus Biotherapeutics: Promising Clinical Developments and Strategic Merger with Clywedog Therapeutics
4M ago
BRNS
Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
PremiumThe Fly
Barinthus Biotherapeutics price target raised to $4 from $3 at H.C. Wainwright
4M ago
BRNS
Barinthus Biotherapeutics Reports Q3 2025 Earnings
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Q3 2025 Earnings
5M ago
BRNS
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
PremiumThe Fly
Barinthus Biotherapeutics reports Q3 EPS (36c) vs (21c) last year
5M ago
BRNS
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
PremiumCompany Announcements
Barinthus Biotherapeutics Advances Celiac Disease Treatment with VTP-1000 Trial
5M ago
BRNS
Barinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
PremiumCompany AnnouncementsBarinthus Biotherapeutics Announces Merger with Clywedog Therapeutics
6M ago
8K
BRNS
Barinthus Bio, Clywedog enter definitive merger agreement
Premium
The Fly
Barinthus Bio, Clywedog enter definitive merger agreement
6M ago
BRNS
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
Premium
Ratings
Barinthus Biotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
8M ago
BRNS
Barinthus Biotherapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Barinthus Biotherapeutics Reports Q2 2025 Financial Results
8M ago
BRNS
Barinthus Biotherapeutics reports Q2 EPS (52c) vs. (49c) last year
PremiumThe Fly
Barinthus Biotherapeutics reports Q2 EPS (52c) vs. (49c) last year
8M ago
BRNS
Barinthus Biotherapeutics sees cash runway into 2027
PremiumThe Fly
Barinthus Biotherapeutics sees cash runway into 2027
8M ago
BRNS
Barinthus Biotherapeutics Approves Key Proposals at AGM
PremiumCompany Announcements
Barinthus Biotherapeutics Approves Key Proposals at AGM
10M ago
8K
BRNS
Barinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
PremiumRatingsBarinthus Biotherapeutics: Strategic Advancements and Financial Strength Support Buy Rating
11M ago
BRNS
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Barinthus Biotherapeutics Reports Q1 2025 Financial Results
11M ago
BRNS
Barinthus Biotherapeutics Restructures Leadership with New CFO
Premium
Company Announcements
Barinthus Biotherapeutics Restructures Leadership with New CFO
11M ago
8K
BRNS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >